| The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism. | |
| | |
MedLine Citation:
|
PMID: 15762035 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The aim of our study was to assess the changes in serum lipid profiles after replacement therapy with L-T4 in patients with subclinical hypothyroidism (SCH), and to see whether there is an improvement in dyslipidemia based cardiovascular risk. Thirty non-smoker pre-menopausal women with newly diagnosed SCH (TSH between 4 and 10 microIU/ml) were involved in our study; twenty-six euthyroid healthy subjects were used as control group. TSH, free T3 (FT3), free T4 (FT4), total cholesterol (TC), triglyceride (TG), HDL cholesterol (HDL-C) and LDL cholesterol (LDL-C) levels were measured before and after 6 months of L-T4 (50-100 microg/ day) therapy. TSH levels were targeted as < 2.0 microIU/ml. LDL-C was calculated using the Friedewald formula, while the cardiovascular risk was assessed with the TC/HDL-C ratio. Pre-treatment serum TC and LDL-C concentrations in SCH patients were significantly higher than those of euthyroid subjects (199.8 +/- 22.2 vs 181.5 +/- 24.6 mg/dl, p < 0.01; 146.3 +/- 26.1 vs 124.8 +/- 12 mg/dl, p < 0.001, respectively). TC, LDL-C levels and the TC/HDL-C ratio were reduced significantly after 6-month replacement therapy (-21.1 +/- 34.4 mg/dl or -10.5%, p < 0.01; -21.5 +/- 30.3 mg/dl or -14.7%, p < 0.001, respectively; and TC/HDL-C from 4.8 +/- 0.6 to 4.1 +/- 0.5 mg/dl, p < 0.01), while body mass index (BMI) values did not change. In conclusion, even mild elevations of TSH are associated with changes in lipid profile significant enough to raise the cardiovascular risk ratio, and these changes are corrected once the patients have been rendered euthyroid. |
| | |
Authors:
|
R Serter; B Demirbas; B Korukluoglu; C Culha; E Cakal; Y Aral |
Related Documents
:
|
2119545 - A three-year evaluation of metabolic changes in singaporean norplant-2 rod acceptors. 16705875 - Dyslipidemia in industrial workers in hot environments. 2956055 - Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.15... 20385115 - Changes in lipid profile in response to three different protocols of whole-body cryosti... 1350465 - A dna polymorphism for lcat is associated with altered lcat activity and high density l... 17699055 - Effect of milk allowance on concentrate intake, ruminal environment, and ruminal develo... |
Publication Detail:
|
Type: Clinical Trial; Journal Article |
Journal Detail:
|
Title: Journal of endocrinological investigation Volume: 27 ISSN: 0391-4097 ISO Abbreviation: J. Endocrinol. Invest. Publication Date: 2004 Nov |
Date Detail:
|
Created Date: 2005-03-14 Completed Date: 2005-06-07 Revised Date: 2005-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7806594 Medline TA: J Endocrinol Invest Country: Italy |
Other Details:
|
Languages: eng Pagination: 897-903 Citation Subset: IM |
Affiliation:
|
Endocrinology and Metabolism, Ankara Education and Research Hospital, Ankara, Turkey. serter@ato.org.tr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Body Mass Index Cardiovascular Diseases / etiology*, prevention & control* Cholesterol / blood Female Humans Hypothyroidism / complications, drug therapy* Lipid Metabolism Lipids / blood* Risk Factors Thyroxine / therapeutic use* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Lipids; 57-88-5/Cholesterol; 7488-70-2/Thyroxine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Informed consent in China: quality of information provided to participants in a research project.
Next Document: Effects of 17beta-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleu...